CAPLIPOINT — Caplin Point Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹174.93bn
- IN₹164.61bn
- IN₹21.87bn
Brief: Caplin Point Laboratories Says Anvisa-Brazil Completes Inspection Of Unit's Facility
Brief: Caplin Point Laboratories's Unit Completes U.S. FDA Inspection With No Observations
Brief: Caplin Point Labs Says Caplin Steriles Gets US FDA Approval For Timolol Maleate Ophthalmic Solution USP
Brief: Caplin Point Laboratories June-Quarter Consol Net Profit 1.24 Bln Rupees
Brief: Caplin Point Laboratories Says Caplin Steriles Gets US FDA Approval For Phenylephrine Hydrochloride Ophthalmic Solution
Brief: Caplin Point Laboratories Says Caplin Steriles Gets US FDA Approval For Ofloxacin Ophthalmic Solution
Brief: Caplin Point Laboratories Says Caplin Steriles Gets USFDA Approval For Ketorolac Tromethamine Ophthalmic
Brief: Caplin Point Laboratories Says Commencement Of Operations By Caplin One Labs
Indian pharma firm Caplin Point Labs up on higher Q3 profit
India's Caplin Point Laboratories hits record high on pact with Tamil Nadu govt
Brief: Caplin Point Laboratories Says Caplin Group Announces Strategic Investment Of 7 Billion Rupees In Tamil Nadu
Brief: Caplin Point Laboratories Gets Us FDA Approval For Ofloxacin Otic Solution
India's Caplin Point Labs up after Q2 profit jump
Brief: India's Caplin Point Laboratories Ltd Sept-Quarter Consol Net Profit Rises
Brief: Caplin Point Laboratories Says Unit Final Approval By USFDA
Brief: Caplin Point Laboratories says Caplin Steriles Receives EIR From FDA
Brief: Caplin Point Laboratories June-Qtr Consol Net Profit Rises
Brief: Caplin Point Laboratories Says Unit Approved Incorporation Of Wholly Owned Subsidiary In US
Brief: Caplin Point Laboratories Says Unit Gets USFDA Approval For Cisatracurium Besylate Injection